Alemtuzumab to Treat Severe Aplastic Anemia

Clinical trial NCT00195624 · COMPLETED

Trial details

NCT number: NCT00195624
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Aplastic Anemia, Refractory Severe Aplastic Anemia, Relapse

Start date: 2005-09-15
Primary completion: 2014-04-14
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.